Editorial: Management of pancreatic cancer: Defining the targets for therapy

Front Med (Lausanne). 2022 Aug 3:9:971067. doi: 10.3389/fmed.2022.971067. eCollection 2022.

Author

Nam Q Nguyen^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, SA, Australia.
² School of Medicine, University of Adelaide, Adelaide, SA, Australia.

No abstract available

Keywords: CHFR; biomarkers; high mobility group box 1 (HMGB1); pancreatic cancer; patient-derived-organoid (PDO); targeted therapy.

Publication types

Editorial